share_log

Silverback Therapeutics | PREM14A: Preliminary proxy statements relating to merger or acquisition

Aug 11, 2022 17:22
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more